Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Int J Infect Dis ; 80: 129-133, 2019 Mar.
Article in English | MEDLINE | ID: mdl-30572022

ABSTRACT

OBJECTIVE: This study was performed to analyze the serotype distribution of Streptococcus pneumoniae causing invasive pneumococcal disease (IPD) in children aged 5 years and under in Malaysia and to assess the antimicrobial resistance. METHODS: From 2014 to 2017, a total of 245 invasive S. pneumoniae isolates from children ≤5 years of age were received from hospitals all around Malaysia. All isolates were identified and subjected to serotyping and antimicrobial susceptibility testing. RESULTS: Of the 245 isolates, 117 (48.0%) were from children aged <1year, 46 (19.05%) were from children aged 1-2 years, and 82 (33.0%) were from children aged 2-5 years. The most common serotypes were 14 (26.9%), 6B (19.6%), 19A (11.8%), 6A (10.6%), and 19F (6.9%) and vaccine coverage was 88.2% for PCV13, 64.1% for PCV10, and 63.3% for PCV7. Resistance to penicillin was 0.2% for non-meningitis cases and 22.2% for meningitis cases; erythromycin resistance was reported in 42.9%, co-trimoxazole in 35.9%, and tetracycline in 42.9%. CONCLUSIONS: Serotypes 14, 6B, 19A, 6A, and 19F were the most common serotypes isolated from children with IPD in Malaysia during this pre-vaccination era. The lack of reports on the serotype distribution has limited action for the implementation of PCV in the national immunization programme (NIP). The information from this study may benefit future policies for the introduction of PCV in the Malaysian NIP and ultimately may reduce the morbidity and mortality among children in Malaysia.


Subject(s)
Drug Resistance, Multiple, Bacterial , Pneumococcal Infections/epidemiology , Streptococcus pneumoniae/isolation & purification , Anti-Bacterial Agents/therapeutic use , Child, Preschool , Erythromycin/therapeutic use , Female , Heptavalent Pneumococcal Conjugate Vaccine/therapeutic use , Hospitals , Humans , Infant , Malaysia/epidemiology , Male , Penicillins/therapeutic use , Pneumococcal Vaccines/therapeutic use , Serogroup , Serotyping , Streptococcus pneumoniae/drug effects , Tetracycline/therapeutic use , Trimethoprim, Sulfamethoxazole Drug Combination/therapeutic use , Vaccination , Vaccination Coverage
SELECTION OF CITATIONS
SEARCH DETAIL
...